S H Kelkar & Company Ltd
S H Kelkar and Company Limited is engaged in manufacture, supply and exports of fragrances and aroma ingredients[1] It is the largest domestic fragrance producer in India and the only company of Indian origin to file patents in the field of Fragrance & Novel aroma molecules.
- Market Cap ₹ 1,750 Cr.
- Current Price ₹ 126
- High / Low ₹ 276 / 112
- Stock P/E 212
- Book Value ₹ 53.4
- Dividend Yield 0.79 %
- ROCE 3.20 %
- ROE 1.12 %
- Face Value ₹ 10.0
Pros
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 11.0% over past five years.
- Company has a low return on equity of 7.46% over last 3 years.
- Contingent liabilities of Rs.655 Cr.
- Earnings include an other income of Rs.66.4 Cr.
- Promoter holding has decreased over last 3 years: -3.78%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals
Part of BSE Commodities BSE 1000
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 471 | 559 | 615 | 682 | 694 | 719 | 761 | 807 | 880 | 941 | 1,137 | 1,280 | |
| 405 | 466 | 514 | 579 | 629 | 646 | 661 | 722 | 754 | 806 | 1,055 | 1,250 | |
| Operating Profit | 66 | 93 | 101 | 103 | 65 | 73 | 100 | 85 | 125 | 134 | 82 | 30 |
| OPM % | 14% | 17% | 16% | 15% | 9% | 10% | 13% | 11% | 14% | 14% | 7% | 2% |
| 32 | 24 | 11 | 14 | 19 | 10 | 34 | 13 | -16 | 21 | -55 | 66 | |
| Interest | 13 | 14 | 3 | 3 | 7 | 12 | 6 | 4 | 5 | 7 | 19 | 27 |
| Depreciation | 15 | 13 | 7 | 11 | 15 | 28 | 28 | 28 | 27 | 26 | 26 | 29 |
| Profit before tax | 70 | 89 | 103 | 103 | 62 | 43 | 100 | 66 | 77 | 123 | -18 | 41 |
| Tax % | 12% | 26% | 28% | 33% | 28% | 26% | 20% | 36% | 32% | 23% | -27% | 19% |
| 62 | 66 | 74 | 69 | 45 | 32 | 80 | 42 | 52 | 94 | -14 | 33 | |
| EPS in Rs | 4.66 | 4.54 | 5.14 | 4.77 | 3.11 | 2.26 | 5.64 | 3.07 | 3.77 | 6.81 | -0.98 | 2.41 |
| Dividend Payout % | 23% | 33% | 34% | 37% | 0% | 42% | 31% | 24% | 53% | 11% | -102% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 11% |
| 3 Years: | 13% |
| TTM: | 13% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -19% |
| 5 Years: | -37% |
| 3 Years: | -50% |
| TTM: | -86% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -5% |
| 5 Years: | -4% |
| 3 Years: | 6% |
| 1 Year: | -47% |
| Return on Equity | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 8% |
| 3 Years: | 7% |
| Last Year: | 1% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 132 | 145 | 145 | 145 | 145 | 141 | 141 | 138 | 138 | 138 | 138 | 138 |
| Reserves | 168 | 401 | 474 | 483 | 452 | 427 | 494 | 463 | 504 | 620 | 595 | 601 |
| 154 | 0 | 1 | 19 | 87 | 76 | 67 | 47 | 95 | 83 | 326 | 444 | |
| 100 | 114 | 140 | 207 | 207 | 298 | 329 | 370 | 347 | 359 | 380 | 355 | |
| Total Liabilities | 555 | 660 | 759 | 854 | 891 | 943 | 1,031 | 1,018 | 1,086 | 1,201 | 1,439 | 1,539 |
| 94 | 93 | 114 | 154 | 201 | 254 | 222 | 224 | 202 | 186 | 190 | 191 | |
| CWIP | 0 | 0 | 5 | 18 | 24 | 13 | 17 | 3 | 8 | 6 | 23 | 78 |
| Investments | 99 | 167 | 220 | 269 | 269 | 253 | 321 | 322 | 311 | 343 | 502 | 584 |
| 361 | 400 | 421 | 412 | 397 | 422 | 472 | 470 | 565 | 666 | 724 | 686 | |
| Total Assets | 555 | 660 | 759 | 854 | 891 | 943 | 1,031 | 1,018 | 1,086 | 1,201 | 1,439 | 1,539 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 21 | 45 | 67 | 118 | 105 | 187 | 84 | 84 | -11 | 30 | -13 | 99 | |
| 26 | -57 | -92 | -88 | -87 | -32 | -65 | 10 | -24 | -20 | -178 | -160 | |
| 0 | 3 | -3 | -49 | -13 | -124 | -24 | -116 | 33 | 4 | 182 | 55 | |
| Net Cash Flow | 47 | -9 | -28 | -19 | 5 | 31 | -5 | -21 | -3 | 14 | -8 | -6 |
| Free Cash Flow | 25 | 33 | 50 | 48 | 18 | 159 | 69 | 72 | -13 | 22 | -47 | -12 |
| CFO/OP | 51% | 74% | 102% | 143% | 190% | 272% | 96% | 127% | 11% | 45% | -6% | 384% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 59 | 75 | 82 | 100 | 66 | 74 | 96 | 73 | 59 | 66 | 52 | 66 |
| Inventory Days | 244 | 217 | 198 | 147 | 164 | 147 | 136 | 185 | 239 | 269 | 188 | 132 |
| Days Payable | 65 | 94 | 71 | 131 | 127 | 199 | 211 | 234 | 193 | 192 | 151 | 115 |
| Cash Conversion Cycle | 238 | 198 | 209 | 117 | 103 | 23 | 21 | 25 | 104 | 143 | 89 | 84 |
| Working Capital Days | 45 | 151 | 160 | 99 | 52 | 8 | 22 | 23 | 43 | 71 | 41 | 3 |
| ROCE % | 17% | 21% | 18% | 17% | 10% | 8% | 16% | 10% | 15% | 16% | 8% | 3% |
Insights
In beta| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Number of Manufacturing Facilities Number |
|
|||||||||
| Number of Customers Number |
||||||||||
| Number of Perfumers Number |
||||||||||
| Number of Scientists Number |
||||||||||
| Number of Dealers and Distributors Number |
||||||||||
| Number of Patent Applications Filed Number |
||||||||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
9h - We are enclosing herewith the transcript of the Conference Call for Investors and Analysts for Q4 FY26 results
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
18 May - Audio recording of May 18, 2026 Q4 and FY26 investor call available online.
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
16 May - Submitted FY26 Secretarial Compliance Report; one Regulation 30 disclosure was delayed beyond 24 hours.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
16 May - Newspaper Publication in respect of Audited Standalone and Consolidated Financial Results for the quarter and financial year ended March 31, 2026
-
Announcement under Regulation 30 (LODR)-Investor Presentation
15 May - Submission of Investor Presentation in respect of Audited (Standalone and Consolidated) Financial Results for the quarter and year ended March 31,2026.
Annual reports
Concalls
-
May 2026Transcript PPT REC
-
Feb 2026Transcript PPT REC
-
Feb 2026TranscriptAI SummaryPPT
-
Nov 2025Transcript PPT REC
-
Aug 2025TranscriptAI SummaryPPT
-
May 2025Transcript PPT
-
Feb 2025Transcript PPT
-
Nov 2024Transcript PPT
-
Aug 2024Transcript PPT
-
May 2024Transcript PPT
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Aug 2023Transcript PPT
-
Jun 2023Transcript PPT
-
Feb 2023TranscriptPPT
-
Feb 2023Transcript PPT
-
Feb 2023TranscriptAI SummaryPPT
-
Nov 2022Transcript PPT
-
Oct 2022TranscriptAI SummaryPPT
-
Aug 2022Transcript PPT
-
Jun 2022Transcript PPT
-
Feb 2022Transcript PPT
-
Nov 2021Transcript PPT
-
Aug 2021Transcript PPT
-
Jul 2021TranscriptAI SummaryPPT
-
Jun 2021Transcript PPT
-
Feb 2021Transcript PPT
-
Dec 2020Transcript PPT
-
Nov 2020TranscriptAI SummaryPPT
-
Sep 2020TranscriptPPT
-
Sep 2020Transcript PPT
-
Jul 2020TranscriptPPT
-
May 2020TranscriptAI SummaryPPT
-
Feb 2020Transcript PPT
-
Nov 2019Transcript PPT
-
Sep 2019Transcript PPT
-
Jun 2019TranscriptPPT
-
May 2019TranscriptAI SummaryPPT
-
Feb 2019Transcript PPT
-
Dec 2018Transcript PPT
-
Sep 2018Transcript PPT
-
Aug 2018TranscriptAI SummaryPPT
-
Jun 2018Transcript PPT
-
Feb 2018TranscriptPPT
-
Jan 2018Transcript PPT
-
Nov 2017TranscriptPPT
-
Oct 2017TranscriptAI SummaryPPT
-
Sep 2017Transcript PPT
-
Jun 2017TranscriptPPT
-
Mar 2017Transcript PPT
-
Nov 2016Transcript PPT
-
Sep 2016TranscriptPPT
-
Aug 2016TranscriptAI SummaryPPT
-
Jun 2016Transcript PPT
-
Mar 2016TranscriptPPT
Product Portfolio[1]
a) Fragrance Products: Used in personal wash, fabric care, skin and hair care, fine fragrances, and household products
b) Flavour Products: Used in baked goods, dairy products, beverages, and pharmaceuticals
c) Aroma Ingredients & Natural Actives: Includes specially created molecules and patented ingredients for personal care and flavors, some of which have commercial success in deodorants and fine fragrance